ArticleCancer management and research2023

Safety and Efficacy of Concurrent or Sequential Radiotherapy Plus (PD-1) Inhibitors in Oligometastatic Esophageal Cancer.

Yanan Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.